Celanese (CE)
(Delayed Data from NYSE)
$156.69 USD
-4.73 (-2.93%)
Updated May 10, 2024 04:00 PM ET
After-Market: $156.65 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$156.69 USD
-4.73 (-2.93%)
Updated May 10, 2024 04:00 PM ET
After-Market: $156.65 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Zacks News
Valvoline's (VVV) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Valvoline's (VVV) fiscal second-quarter earnings and revenues surpass estimates on higher system-wide same-store sales.
Celanese's (CE) Q1 Earnings Surpass Estimates, Sales Lag
by Zacks Equity Research
Net sales of Engineered Materials unit of Celanese (CE) decrease sequentially on lower volumes and prices in Q1.
Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Celanese (CE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese (CE) is expected to have benefited from cost-cutting and efficiency initiatives, as well as investments in high-return organic projects and acquisition synergies in Q1.
Countdown to Celanese (CE) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Celanese (CE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Green Plains Renewable Energy (GPRE) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Green Plains (GPRE) delivered earnings and revenue surprises of -145.45% and 13.71%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Celanese (CE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Daqo New Energy (DQ) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Daqo (DQ) delivered earnings and revenue surprises of -57.14% and 15.57%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Celanese (CE) in Your Portfolio
by Zacks Equity Research
While Celanese (CE) faces challenges from demand softness and pricing pressures, it benefits from strategic acquisitions and productivity measures.
Celanese (CE) Achieves Milestones in the Acetyl Chain Business
by Zacks Equity Research
Celanese (CE) achieves milestones in cost-effective, sustainable growth, including new facilities and supply contracts, positioning for earnings increase and global expansion.
Celanese (CE) Up 39% in 6 Months: What's Driving the Rally?
by Zacks Equity Research
Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.
Celanese (CE) Gets ISCC-Certified for Low Carbon CCU Methanol
by Zacks Equity Research
Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions, acquisitions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
Celanese (CE) and Secarna Partner for Antisense Therapies
by Zacks Equity Research
Celanese's (CE) collaboration with Secarna enables the development of a novel implant with the potential to significantly alter how disease-modifying ASO treatments are given.
Why Is Celanese (CE) Up 10% Since Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold Onto Celanese (CE) Stock For Now
by Zacks Equity Research
While Celanese (CE) faces headwinds from demand softness and pricing pressures, it gains on strategic acquisitions and productivity measures.
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR
by Zacks Equity Research
iDose TR uses Celanese's (CE) VitalDose EVA. It is approved following the completion of two pivotal trials which demonstrates safety and efficacy.
Celanese's (CE) Earnings and Revenues Miss Estimates in Q4
by Zacks Equity Research
Pricing of Celanese's (CE) Engineered Material segment declines in Q4 due to tough competition and product mix challenges in the Americas and Europe.
Celanese (CE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
January CPI Comes in Hot But Underlying Inflation Pressures Remain Cool
by Mayur Thaker
i still expect core inflation to remain subdued which should keep a lid on yields, but cracks in consumer health and valuations remain top concerns
Celanese (CE) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -2.18% and 1.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CE or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. BCPC: Which Stock Is the Better Value Option?
Celanese (CE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q4.
Earnings Preview: Mativ Holdings (MATV) Q4 Earnings Expected to Decline
by Zacks Equity Research
Mativ Holdings (MATV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Countdown to Celanese (CE) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Celanese (CE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.